Your shopping cart is currently empty

m-PEG-NHS ester (MW 550) is used to modify active molecules to enhance their antigenicity and immunogenicity, aiding in the preparation of injectable formulations. Modification with m-PEG-NHS ester does not affect the strong fibrinolytic and thrombolytic activities of the serine protease Lumbrokinase (LK), offering promising application potential.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 mg | Inquiry | Inquiry | Inquiry | |
| 100 mg | Inquiry | Inquiry | Inquiry | |
| 250 mg | Inquiry | Inquiry | Inquiry |
| Description | m-PEG-NHS ester (MW 550) is used to modify active molecules to enhance their antigenicity and immunogenicity, aiding in the preparation of injectable formulations. Modification with m-PEG-NHS ester does not affect the strong fibrinolytic and thrombolytic activities of the serine protease Lumbrokinase (LK), offering promising application potential. |
| Synonyms | mPEG-Succinimidyl ester (MW 550), mPEG-SC (MW 550), m-PEG-NHS ester (MW 550) |
| Molecular Weight | 550(Average) |
| Formula | (C2H4O)nC7H9NO5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.